CN101747393B - Method for simultaneously preparing chemical references of icariin, epimedin A, epimedin B and epimedin C - Google Patents

Method for simultaneously preparing chemical references of icariin, epimedin A, epimedin B and epimedin C Download PDF

Info

Publication number
CN101747393B
CN101747393B CN2008102298880A CN200810229888A CN101747393B CN 101747393 B CN101747393 B CN 101747393B CN 2008102298880 A CN2008102298880 A CN 2008102298880A CN 200810229888 A CN200810229888 A CN 200810229888A CN 101747393 B CN101747393 B CN 101747393B
Authority
CN
China
Prior art keywords
epimedin
performance liquid
yellow powder
icarin
purity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008102298880A
Other languages
Chinese (zh)
Other versions
CN101747393A (en
Inventor
肖红斌
王莉
雷宇佳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN2008102298880A priority Critical patent/CN101747393B/en
Publication of CN101747393A publication Critical patent/CN101747393A/en
Application granted granted Critical
Publication of CN101747393B publication Critical patent/CN101747393B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

The invention relates to a separation preparation method for simultaneously preparing chemical references of icariin, epimedin A, epimedin B and epimedin C, which comprises the following steps: using icariin extracts with the content between 10 percent and 50 percent as raw materials; carrying out primary column separation; using the preparation type high-efficient liquid phase chromatogram as a main separation measure; carrying out two steps of high-efficient liquid phase preparation; and directly concentrating an extracting solution through pressure reduction until the extracting solution is dried to obtain the chemical references of icariin, epimedin A, epimedin B and epimedin C with the purity higher than 98 percent. The invention has the advantages of simple process step, high purity and good color and luster effect, and can realize the large-scale production.

Description

The method for preparing icarin, epimedin A, B, C chemical reference substance simultaneously
Technical field
The present invention relates to a kind of separation novel preparation method for preparing icarin, epimedin A, B, C chemical reference substance simultaneously.Comprise that mainly post separates enrichment method and performance liquid preparation method removal of impurities fast and refining.The structural formula of four kinds of reference substances is following:
Figure G2008102298880D00011
R1 R2 R3
Epimedin A:rha-(1-2) glu glu CH3
Epimedin B:rha-(1-2) xyl glu CH3
Epimedin: rha-(1-2) rha glu CH3
Icariine: rha glu CH3
Background technology
Herba Epimedii (Herba Epimedii) is that China uses one of the longest Chinese medicine, has the effect of kidney-replenishing, strengthening the bones and tendons, wind-damp dispelling.Modern study shows that Herba Epimedii has many-sided pharmacological actions such as osteoporosis, sexual function improving, increase cardiovascular and cerebrovascular blood flow.Icarin is the main active ingredient of Herba Epimedii, also is the assay composition of epimedium herb in 2005 editions NFs of China; And epimedin A, B, C to be the glycosyl of icarin replace analogue and belong to high-content composition (Zhang Huafeng etc., analytical test journal, 2007,26 (2): 198-201 of per mille level; Thank to beautiful equality, herbal medicine, 2007,38 (4): 613-614), therefore, the many index determinings that epimedium herb carried out simultaneously epimedin A, B, C and icarin are significant.But, as the quality control index composition, must there be a large amount of chemical reference substances to provide, at present, except that icarin, rare providing on other three kinds of reference substance markets.For preparing method's research of reference substance, concentrate on mainly at present that (Hu Yunfeng etc., Chinese patent CN200510061251.1 disclosed in 2007 in the separation and purification of icarin and epimedin; Guo Baolin etc., Chinese patent CN2007100002610.5,2007 are open; Wang Xiaochun etc., Chinese patent CN200610101222.5,2007 are open), and the preparation that separates of epimedin A and B is not almost reported.
Summary of the invention
The present invention is on the scale preparation basis of early-stage Study icarin and epimedin; Many-sided researchs such as, target reference substance enriching method research preferred and the exploitation of reference substance refined highly effective liquid phase process through bulk drug; The invention provides a kind of low cost, high performance liquid preparative chromatography method fast; Can prepare purity simultaneously greater than 98% epimedin A, B, C and icarin, and single reference substance preparative-scale can reach the 1g/ month, the accumulative total preparative-scale can reach monthly output 5g reference substance.
For realizing above-mentioned purpose, the technical scheme that the present invention adopts:
The method for preparing icarin, epimedin A, B, C chemical reference substance simultaneously; The icarin extract that with the mass content is 10%-50% is a raw material, separates through preliminary post, and be main separation means with preparative high performance liquid chromatography; Through the performance liquid preparation of two steps; Extracting solution directly is evaporated to do and can obtains purity greater than 98% corresponding reference substance, and scale be each reference substance monthly output 1 gram, totally produces the 5g reference substance per month; Concrete steps are following:
1) preliminary post separates:
Icarin extract water or the dissolving of volumetric concentration 40-80% aqueous ethanolic solution; Resin column or polyamide column separate, the ethanol-water solution gradient elution, and wherein the alcoholic acid volumetric concentration changes from 0%-100%; Collect 20%-80% ethanol elution thing, concentrate drying gets yellow powder I;
2) the first step performance liquid preparation:
Yellow powder I is configured to the need testing solution that concentration is 50~150mg/ml with the dissolving of volumetric concentration 40-80% aqueous ethanolic solution, through 0.45 μ m filtering with microporous membrane; Adopt the high performance liquid preparative chromatography post of column length 10-50cm, diameter 1-10cm to separate; Six-way valve or pump sample introduction; Sampling volume is 1-50ml, is that the methanol-water of 45-60% or acetonitrile-aqueous solution that volumetric concentration is 20-40% are eluent system with the volumetric concentration, and flow rate control is at 10-400ml/min; Online ultraviolet detection is collected the elutriant (stream part 1) that contains epimedin A and B respectively; The elutriant (stream part 2) that contains epimedin and icarin, more than two stream part dry respectively a yellow powder II and yellow powder III;
3) second step performance liquid preparation:
Yellow powder II is that the acetonitrile solution that contains of 20-40% is that eluent system is carried out the performance liquid preparation second time with the volumetric concentration, and all the other conditions are with step 2), the epimedin A that collects purity>98% respectively flows stream part of the epimedin B of part and purity>98%.
Yellow powder III is that the acetonitrile solution that contains of 20-40% is that eluent system is carried out the performance liquid preparation second time with the volumetric concentration, and all the other conditions are with step 2), collect purity respectively greater than high-purity stream part of containing epimedin and icarin of 98%;
4) acquisition of target chemical reference substance:
More than four kinds of high-purity stream parts directly be concentrated into to do and can obtain purity greater than 98% corresponding reference substance, it is the glassy yellow powder.
In the aforesaid method, preliminary post separates better with nonpolar macroporous adsorption resin with resin.The filler of performance liquid preparative column is C6, C8 or C18 bonded phase packings, and its particle diameter is 5~20 μ m, the preferred 270nm of ultraviolet detection wavelength, 318nm or 349nm, specifically detect wavelength per sample in target reference substance signal the overload situation and decide.
From Herba Epimedii extract, separate epimedin A, B, C and icarin chemical reference substance with the present invention and have following advantage and progress:
1. the present invention is a separation means with preparation type performance liquid, and separation efficiency is high, can guarantee the purity of reference substance.
2. the present invention carries out preliminary enrichment through the post separation to the target reference substance, adopts two step performance liquid preparing methods to carry out removal of impurities respectively with refining then, and technology is simpler.
3, the performance liquid preparation method of the present invention's development is a fast preparation method, and the single needle disengaging time was fit to the preparation of chemical reference substance in enormous quantities very much between 10-30 minute; Add the recycling of preparation solvent simultaneously, can realize the low cost of batch preparations.
4. the present invention adopts the online detection of UV-detector, and the separation case of each reference substance can directly detect, direct selective collection high purity sample, thus realize the high-recovery of purity under guaranteeing.
In a word, process step of the present invention is simple, purity is high, color and luster is good, and can be mass-produced.
Description of drawings
Fig. 1 is that the HPLC of epimedin A analyzes collection of illustrative plates (270nm), and its integration is reported as follows:
?Name Retention?Time Area %Area
1 2.568 251910 1.20
2 3.087 13633 0.07
3 3.361 1265 0.01
4 3.520 54871 0.26
5 Epimedin A 7.038 20635806 98.47
Fig. 2 is that the HPLC of epimedin B analyzes collection of illustrative plates (270nm), and its integration is reported as follows:
?Name Retention?Time Area %Area
1 1.368 48442 0.18
2 1.571 25759 0.09
3 1.793 36112 0.13
4 2.527 320702 1.18
5 3.364 5271 0.02
6 3.509 3416 0.01
7 Epimedin B 7.584 26786204 98.39
Fig. 3 is that the HPLC of epimedin analyzes collection of illustrative plates (270nm), and its integration is reported as follows:
?Name Retention?Time Area %Area
1 2.498 210103 1.02
2 3.184 4929 0.02
3 3.360 9203 0.04
4 Epimedin 8.315 20358900 98.91
Fig. 4 is that the HPLC of icarin (epimedin D) analyzes collection of illustrative plates (270nm), and its integration is reported as follows:
Name Retention?Time Area %Area
1 0.615 252448 0.92
2 2.554 204808 0.75
3 Icarin 10.264 26778047 98.33
Embodiment
Combine embodiment and accompanying drawing that the present invention is explained further details, embodiment only limits to explain the present invention at present, but not to qualification of the present invention.
Embodiment 1
In the present embodiment; With content is that 20% icarin extract is a raw material; Preliminary post separates employing HPD post; The performance liquid preparation is a sorbent material with 10 μ mC18 bonded phase packings, and adopting a certain proportion of methanol-water and acetonitrile-water respectively is eluting solvent, prepares each reference substance through two step performance liquid.Concrete process step is following:
1) preliminary post separates
The icarin extract dissolves with 40% aqueous ethanolic solution, and the HPD-100 resin column separates, and the ethanol-water solution gradient elution is collected 20%-80% ethanol elution thing, and concentrate drying gets yellow powder I.
2) the first step performance liquid preparation
Yellow powder I dissolves with 40% aqueous ethanolic solution, is configured to the need testing solution that concentration is 150mg/ml, through 0.45 μ m filtering with microporous membrane; Preparation type performance liquid column packing brand is the ChromatorexC18 bonded phase packings; Particle diameter is 10 μ m, column length 22cm, diameter 7.5cm; Six-way valve sample introduction, sampling volume are 10ml, are eluent system with 55% methanol-water solution, and flow rate control is at 160ml/min, and online ultraviolet detection is collected the elutriant (stream part 1) that contains epimedin A and B respectively; The elutriant (stream part 2) that contains epimedin and icarin, more than two stream part respectively concentrating under reduced pressure dry yellow powder II and yellow powder III.
3) second step performance liquid preparation
Yellow powder II is that 30% the acetonitrile solution that contains is that eluent system is carried out the performance liquid preparation second time with volumetric concentration, and all the other conditions are with step 2), collect high-purity stream part of containing epimedin A, B respectively.
Yellow powder III with volumetric concentration be 30% the acetonitrile solution that contains be that eluent system is carried out the performance liquid preparation second time, all the other conditions are with step 2), collect high-purity stream part of containing epimedin and icarin respectively.
4) acquisition of each chemical reference substance
Above-mentioned each high-purity stream part directly is concentrated into to do and can obtains purity greater than 98% each corresponding reference substance epimedin A, B, C and icarin (Fig. 1-Fig. 4).
Embodiment 2
In the present embodiment; With content is that 20% icarin extract is a raw material; Preliminary post separates employing HPD post; The performance liquid preparation is a sorbent material with 10 μ mC18 bonded phase packings, and adopting a certain proportion of methanol-water and acetonitrile-water respectively is eluting solvent, prepares each corresponding reference substance through two step performance liquid.Concrete process step is following:
1) preliminary post separates
The icarin extract dissolves with the aqueous solution, and the HPD-100 resin column separates, and the ethanol-water solution gradient elution is collected 20%-80% ethanol elution thing, and concentrate drying gets yellow powder I.
2) the first step performance liquid preparation
Yellow powder I dissolves with 50% aqueous ethanolic solution, is configured to the need testing solution that concentration is 100mg/ml, through 0.45 μ m filtering with microporous membrane; Preparation type performance liquid column packing brand is the ChromatorexC18 bonded phase packings; Particle diameter is 10 μ m, column length 19cm, diameter 7.5cm; Pump sample introduction, sampling volume are 20ml, are eluent system with 60% methanol-water solution, and flow rate control is at 140ml/min, and online ultraviolet detection is collected the elutriant (stream part 1) that contains epimedin A and B respectively; The elutriant (stream part 2) that contains epimedin and icarin, more than two stream part respectively concentrating under reduced pressure dry yellow powder II and yellow powder III.
3) second step performance liquid preparation
Yellow powder II is that 25% the acetonitrile solution that contains is that eluent system is carried out the performance liquid preparation second time with volumetric concentration, and all the other conditions are with step 2), collect high-purity stream part of containing epimedin A, B respectively.
Yellow powder III with volumetric concentration be 25% the acetonitrile solution that contains be that eluent system is carried out the performance liquid preparation second time, all the other conditions are with step 2), collect high-purity stream part of containing epimedin and icarin respectively.
4) step is with embodiment 1.
Embodiment 3
In the present embodiment; With content is that 15% icarin extract is a raw material; Preliminary post separates the employing polyamide column; The performance liquid preparation is a sorbent material with 5 μ m C18 bonded phase packings, and adopting a certain proportion of methanol-water and acetonitrile-water respectively is eluting solvent, prepares each corresponding reference substance through two step performance liquid.Concrete process step is following:
1) preliminary post separates
The icarin extract dissolves with 45% aqueous ethanolic solution, and polyamide column separates, and the ethanol-water solution gradient elution is collected 20%-80% ethanol elution thing, and concentrate drying gets yellow powder I.
2) the first step performance liquid preparation
Yellow powder I dissolves with 45% aqueous ethanolic solution, is configured to the need testing solution that concentration is 120mg/ml, through 0.45 μ m filtering with microporous membrane; Preparation type performance liquid column packing brand is the McirosorbC18 bonded phase packings, and particle diameter is 5 μ m; Column length 17cm, diameter 5cm; Six-way valve sample introduction, sampling volume are 8ml, are eluent system with 50-60% methanol-water solution, and flow rate control is at 180ml/min, and online ultraviolet detection is collected the elutriant (stream part 1) that contains epimedin A and B respectively; The elutriant (stream part 2) that contains epimedin and icarin, more than two stream part respectively concentrating under reduced pressure dry yellow powder II and yellow powder III.
3) second step performance liquid preparation
Yellow powder II is that 25% the acetonitrile solution that contains is that eluent system is carried out the performance liquid preparation second time with volumetric concentration, and all the other conditions are with step 2), collect high-purity stream part of containing epimedin A, B respectively.
Yellow powder III with volumetric concentration be 25% the acetonitrile solution that contains be that eluent system is carried out the performance liquid preparation second time, all the other conditions are with step 2), collect high-purity stream part of containing epimedin and icarin respectively.
4) step is with embodiment 1.
Embodiment 4
In the present embodiment; With content is that 25% icarin extract is a raw material; Preliminary post separates the employing polyamide column; The performance liquid preparation is a sorbent material with 5 μ m C18 bonded phase packings, and adopting a certain proportion of methanol-water and acetonitrile-water respectively is eluting solvent, prepares each corresponding reference substance through two step performance liquid.Concrete process step is following:
1) preliminary post separates
The icarin extract dissolves with 40% aqueous ethanolic solution, and polyamide column separates, and the ethanol-water solution gradient elution is collected 20%-80% ethanol elution thing, and concentrate drying gets yellow powder I.
2) the first step performance liquid preparation
Yellow powder I is configured to the need testing solution that concentration is 80mg/ml with the dissolving of 40-80% aqueous ethanolic solution, through 0.45 μ m filtering with microporous membrane; Preparation type performance liquid column packing brand is the McirosorbC18 bonded phase packings, and particle diameter is 5 μ m; Column length 17cm, diameter 5cm; Pump sample introduction, sampling volume are 20ml, are eluent system with 60% methanol-water solution, and flow rate control is at 180ml/min, and online ultraviolet detection is collected the elutriant (stream part 1) that contains epimedin A and B respectively; The elutriant (stream part 2) that contains epimedin and icarin, more than two stream part respectively concentrating under reduced pressure dry yellow powder II and yellow powder III.
3) second step performance liquid preparation
Yellow powder II is that 28% the acetonitrile solution that contains is that eluent system is carried out the performance liquid preparation second time with volumetric concentration, and all the other conditions are with step 2), collect high-purity stream part of containing epimedin A, B respectively.
Yellow powder III with volumetric concentration be 28% the acetonitrile solution that contains be that eluent system is carried out the performance liquid preparation second time, all the other conditions are with step 2), collect high-purity stream part of containing epimedin and icarin respectively.
4) step is with embodiment 1.

Claims (3)

1. the method for preparing icarin, epimedin A, B, C chemical reference substance simultaneously; It is characterized in that: the icarin extract that with the mass content is 10%-50% is a raw material; Separate through preliminary post; With preparative high performance liquid chromatography is main separation means, and through two step performance liquid preparations, extracting solution directly is evaporated to do and can obtains purity greater than 98% corresponding reference substance; Concrete steps are following:
1) preliminary post separates:
Icarin extract water or the dissolving of volumetric concentration 40-80% aqueous ethanolic solution; Resin column or polyamide column separate, the ethanol-water solution gradient elution, and wherein the alcoholic acid volumetric concentration changes from 0%-100%; Collect 20%-80% ethanol elution thing, concentrate drying gets yellow powder I;
2) the first step performance liquid preparation:
Yellow powder I is configured to the need testing solution that concentration is 50~150mg/ml with the dissolving of volumetric concentration 40-80% aqueous ethanolic solution, through 0.45 μ m filtering with microporous membrane; Adopt the high performance liquid preparative chromatography post of column length 10-50cm, diameter 1-10cm to separate; Six-way valve or pump sample introduction, sampling volume is 1-50ml, is that the methanol-water of 45-60% or acetonitrile-aqueous solution that volumetric concentration is 20-40% are eluent system with the volumetric concentration; Flow rate control is at 10-400ml/min; Online ultraviolet detection is collected the elutriant that contains epimedin A and B respectively, and it is stream part 1; The elutriant that contains epimedin and icarin, it is stream parts 2, more than two stream part dry respectively a yellow powder II and yellow powder III;
3) second step performance liquid preparation:
Yellow powder II is that the acetonitrile solution that contains of 20-40% is that eluent system is carried out the performance liquid preparation second time with the volumetric concentration, and all the other conditions are with step 2), the epimedin A that collects purity>98% respectively flows stream part of the epimedin B of part and purity>98%.
Yellow powder III is that the acetonitrile solution that contains of 20-40% is that eluent system is carried out the performance liquid preparation second time with the volumetric concentration, and all the other conditions are with step 2), collect purity respectively greater than high-purity stream part of containing epimedin and icarin of 98%;
4) acquisition of target chemical reference substance:
More than four kinds of high-purity stream parts directly be concentrated into to do and can obtain purity greater than 98% corresponding reference substance, it is the glassy yellow powder;
The filler of the preparative column that the process for preparing the first step or the second step performance liquid adopts is C6, C8 or C18 bonded phase packings, and particle diameter is 5-20 μ m.
2. method according to claim 1 is characterized in that: the resin column that column separation process adopts is the non-polar resin post.
3. method according to claim 1 is characterized in that: performance liquid prepares process and adopts online ultraviolet detection, and it detects the preferred 270nm of wavelength, 318nm or 349nm.
CN2008102298880A 2008-12-17 2008-12-17 Method for simultaneously preparing chemical references of icariin, epimedin A, epimedin B and epimedin C Expired - Fee Related CN101747393B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008102298880A CN101747393B (en) 2008-12-17 2008-12-17 Method for simultaneously preparing chemical references of icariin, epimedin A, epimedin B and epimedin C

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008102298880A CN101747393B (en) 2008-12-17 2008-12-17 Method for simultaneously preparing chemical references of icariin, epimedin A, epimedin B and epimedin C

Publications (2)

Publication Number Publication Date
CN101747393A CN101747393A (en) 2010-06-23
CN101747393B true CN101747393B (en) 2012-04-11

Family

ID=42475065

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008102298880A Expired - Fee Related CN101747393B (en) 2008-12-17 2008-12-17 Method for simultaneously preparing chemical references of icariin, epimedin A, epimedin B and epimedin C

Country Status (1)

Country Link
CN (1) CN101747393B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103698454B (en) * 2013-12-17 2017-01-04 广西中烟工业有限责任公司 A kind of measure the detection method of epimedium active constituent in cigarette shreds and main flume thereof
CN104910216B (en) * 2015-03-07 2017-11-03 宝鸡文理学院 It is a kind of with preparing liquid phase method while obtaining the separation method of a variety of epimedium flavones
CN104788517A (en) * 2015-04-27 2015-07-22 汉中天洋生物科技有限责任公司 Method of using epimedium medicinal material to extract icariin
CN109187810B (en) * 2018-10-29 2021-06-08 广州白云山陈李济药厂有限公司 Detection method of traditional Chinese medicine composition for treating rheumatoid arthritis
CN111675741A (en) * 2020-06-23 2020-09-18 遵义医科大学 Separation method for simultaneously obtaining four kinds of epimedium rare flavone by using preparative liquid phase method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1970566A (en) * 2006-12-06 2007-05-30 贵州同济堂制药有限公司 Epimedin C contrast preparation method and its product

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1970566A (en) * 2006-12-06 2007-05-30 贵州同济堂制药有限公司 Epimedin C contrast preparation method and its product

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
YUJI ITO等.Determination of flavonol glycosides in Epimedii Herba by highperformance liquid chromatography.《Journal of Chromatography》.1988,第456卷第392-397页. *
王丽霞.淫羊藿药材高效液相色谱指纹图谱及质量评估研究.《中国优秀博硕士学位论文全文数据库(硕士)工程科技I辑》.2006,第2006卷(第3期),第B016-81页. *
王超展等.箭叶淫羊藿中5种黄酮类化合物的反相色谱分离制备.《分析化学》.2005,第33卷(第1期),第106-108页. *

Also Published As

Publication number Publication date
CN101747393A (en) 2010-06-23

Similar Documents

Publication Publication Date Title
CN102070690B (en) Method for preparing adenosine, cordycepin and N6-(2-hydroxyethyl)adenosine simultaneously used as chemical reference substances
CN101747393B (en) Method for simultaneously preparing chemical references of icariin, epimedin A, epimedin B and epimedin C
CN105566414B (en) The method that four kinds of flavone glycosides are isolated and purified from waxberry flesh
CN103830306B (en) A kind of preparation method of folium lonicerae effective extract
CN101357147B (en) Extract of dogbane leaf with finger print and preparation and analytical method thereof
CN102070683B (en) Method for simultaneously preparing chemical reference substances of parishin, parishin B and parishin C
CN104447910A (en) Method for preparation of loganin from traditional Chinese medicine Cornus officinalis
CN104610401A (en) Method for simultaneously extracting baicalin, baicalein and wogonin from scutellaria baicalensis
CN105330710B (en) A kind of method for extracting three kinds of iridoid glycosides chemical reference substances simultaneously from the fruit of glossy privet
CN104926659B (en) The method preparing rosmarinic acid chemical reference substance from three kinds of high mountain claries
CN103044253B (en) Extraction separation method of rosmarinic acid in salvia castabea diels f. tomentosa stib
CN103145775A (en) Preparation and quality control method for high purity cleidion brevipetiolatum glycoside A
CN102532077A (en) Method for preparing salvianolic acid B through separation by means of flash chromatography
CN115385901A (en) Method for simultaneously separating schaftoside and trigonelline from pinellia ternata
CN101747391B (en) Method for separating and preparing chemical reference substance of Icariin
CN102503996A (en) Method for extracting active constituent from Swertia mussotii plant
CN101747392B (en) Method for separating and preparing Cepimedin C chemical reference substance
CN104892620B (en) A kind of preparation method of high-purity karanjin
CN102234299B (en) Separation method of hyperin
CN105061212B (en) A kind of preparation method of neochlorogenic acid
CN101210039B (en) Method for separating and preparing madecassoside chemical reference substance
CN102391328B (en) Method for simultaneously preparing chemical reference substances magnoloside A and magnoloside B
CN107011355A (en) The new skeleton flavanols of a class and its method for separating and preparing in Laoyin tea
CN106668234B (en) Rose extraction and purification process for total flavonoids
CN101518565B (en) Method for building wild pueraria lobata extractive HPLC fingerprint

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120411

Termination date: 20191217